Metamizol for the Treatment of Neoplastic Chronic Pain
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Study to evaluate the efficacy of metamizole in reducing morphine requirements in patients
with moderate to severe chronic cancer pain in comparison to administration of placebo or
diclofenac.